studies on glp 1 Discovery of GLP-1–Based Drugs for the Treatment of Obesity GLP-1 Receptor Agonists and Myocardial
Description
This might include dose adjustment, additional support for anxiety management, or consideration of alternative diabetes treatments if deemed necessary
doi: 10.1089/thy.2024.0387
Shaman AM, Bain SC, Bakris G et al (2022) Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER
10.2337/db11-0227 38 FarrO
